21/05/2024  21:55:02 Var. -3.300 Volume Denaro22:00:02 Lettera22:00:02 Capitalizzazione di mercato Dividend Y. Rapporto P/E
94.950EUR -3.36% 804
Fatturato: 77,379.700
-Quantità in denaro: - -Quantità in lettera: - 3.15 bill.EUR 1.32% 27.18

Descrizione business

Gerresheimer is a leading global partner to the pharma and healthcare industry. With its specialty glass and plastic products, the company contributes to health and well-being. It has worldwide operations and about 10,000 employees manufacture the products in local markets, close to its customers. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dietmar Siemssen
Consiglio di amministrazione
Dr. Bernd Metzner, Dr. Lukas Burkhardt
Consiglio di sorveglianza
Dr. Axel Herberg, Francesco Grioli, Andrea Abt, Dr. Karin Louise Dorrepaal, Dr. Peter Noé, Katja Schnitzler, Markus Rocholz, Paul Schilling, Udo J. Vetter, Prof. Dr. Annete G. Köhler, Marlis Mergenthal, Robert Fröhler
 

Dati aziendali

Name: Gerresheimer AG
Indirizzo: Klaus-Bungert-Straße 4,D-40468 Düsseldorf
Telefono: +49-211-6181-00
Fax: +49-211-6181-295
E-mail: info@gerresheimer.com
Internet: www.gerresheimer.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 30/11
Flottante libero: 43.29%
Data dell'IPO: 11/06/2007

Rapporti con gli investitori

Name: Carolin Nadilo
IR telefono: +49-211-6181-314
IR Fax: +49-211-6181-121
IR e-mail: carolin.nadilo@gerre...mer.com carolin.nadilo@gerresheimer.com

Company calendar

CW 23 | 05/06/2024 General Shareholder Meeting
CW 23 | 06/06/2024 Ex-Dividend
CW 23 | 07/06/2024 Record Date
CW 24 | 10/06/2024 Dividend Payment
CW 28 | 11/07/2024 Interim Report 2nd Quarter/6 Months